The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetesDavid Altshuler, Eric S. Lander, Joel N. Hirschhorn et al.|Nature Genetics|2000Cited by 1.8k
Simvastatin with or without Ezetimibe in Familial HypercholesterolemiaJohn J.P. Kastelein, Eric de Groot, Fatima Akdim et al.|New England Journal of Medicine|2008Cited by 1.2k
Hypertriglyceridemic WaistIsabelle Lemieux, Jean‐Pierre Després, Agnès Pascot et al.|Circulation|2000Cited by 934
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trialFrederick J. Raal, Stanley T. Crooke, Raúl D. Santos et al.|The Lancet|2010Cited by 905
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis SocietyHenry N. Ginsberg, Alberico L. Catapano, Jan Borén et al.|European Heart Journal|2021Cited by 889